CoChat

Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19

Published version of a preprint

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

Hepatocellular carcinoma (HCC), one of the leading causes of cancer-related death, develops from premalignant lesions in chronically damaged livers. Although it is well established that FGF19 acts through the receptor complex FGFR4-β-Klotho (KLB) to regulate bile acid metabolism, FGF19 is also implicated in the development of HCC. In humans, FGF19 is amplified in HCC and its expression is induced in the liver under cholestatic and cirrhotic conditions. In mice, ectopic overexpression of FGF19 drives HCC development in a process that requires FGFR4. In this study, we describe an engineered FGF19 (M70) that fully retains bile acid regulatory activity but does not promote HCC formation, demonstrating that regulating bile acid metabolism is distinct and separable from tumor-promoting activity. Mechanistically, we show that FGF19 stimulates tumor progression by activating the STAT3 pathway, an activity eliminated by M70. Furthermore, M70 inhibits FGF19-dependent tumor growth in a rodent model. Our results suggest that selectively targeting the FGF19–FGFR4 pathway may offer a tractable approach to improve the treatment of chronic liver disease and cancer. Cancer Res; 74(12); 3306–16. ©2014 AACR.

Overview

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-14-0208

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 44 references

Research works printed but not linked: 1

  1. Hasegawa, 2013, FGF19 is aberrently expressed in cholestatic hepatocytes and its signaling pathways were downregulated in biliary atresia children, Hepatology, 58, 802A

Cited by

See all 186

Metadata

Authors
Zhou, M., Wang, X., Phung, V., Lindhout, D. A., Mondal, K., Hsu, J.-Y., Yang, H., Humphrey, M., Ding, X., Arora, T., Learned, R. M., DePaoli, A. M., Tian, H., & Ling, L.
Affiliations
NGM Biopharmaceuticals (United States) (US)
Venue
Cancer Research
Published
2014-06-12
Volume
74
Issue
12
Pages
3306-3316
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2166264058
Cited by
183
References
44
Citations by year
2026: 6 · 2025: 11 · 2024: 11 · 2023: 11 · 2022: 17 · 2021: 21 · 2020: 26 · 2019: 16 · 2018: 20 · 2017: 21 · 2016: 7 · 2015: 13 · 2014: 3
FWCI
6.01
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
NGM Biopharmaceuticals
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
Keywords
FGF19, hepatocellular carcinoma, FGFR4, Klotho, bile acid metabolism, tumorigenicity, STAT3 signaling, chronic liver disease, cholestasis, liver cirrhosis
MeSH terms
Dependovirus, Amino Acid Sequence, Animals, Bile Acids and Salts, Cholesterol 7-alpha-Hydroxylase, Fibroblast Growth Factors, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Experimental, Mice, Inbred C57BL, Mice, Obese, Molecular Sequence Data, Protein Binding, Recombinant Proteins, Signal Transduction, Sequence Deletion, Amino Acid Substitution, Cell Line, Tumor, Mice, Rats, Receptor, Fibroblast Growth Factor, Type 4, Carcinogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19. https://app.cochat.ai/papers/10.1158/0008-5472.can-14-0208
The paper
Zhou, M., Wang, X., Phung, V., Lindhout, D. A., Mondal, K., Hsu, J.-Y., Yang, H., Humphrey, M., Ding, X., Arora, T., Learned, R. M., DePaoli, A. M., Tian, H., & Ling, L. (2014). Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19. Cancer Research. https://doi.org/10.1158/0008-5472.can-14-0208

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.